RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Comparative Effectiveness. Monitor federal related to Medicare and other healthcare issues. Healthcare Reform Legislation (H.R. 3200 and S. 1796). Pharmaceutical import safety legislation. Health Legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Health Issues HCR
Monitor federal related to Medicare and other healthcare issues. Budget resolution FY2010. Healthcare Reform Legislation. Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Budget/Appropriations BUD
Comparative Effectiveness and H.R. 1 American Recovery and Reinvestment Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Pharmacy PHA
Issues regarding follow on bologics, HR 3200 and S. 1796.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Medical/Disease Research/Clinical Labs MED
Comparative Effectiveness
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.